Skip to content

Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children with Cerebral Palsy - A Randomized Controlled Trial.

Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children with Cerebral Palsy - A Randomized Controlled Trial. - Power2Walk

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56709
Enrollment
66
Registered
2023-12-22
Start date
2024-07-19
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Interventions

Intervention group: The MegaPower training is a 12 week long functional power training program in which children will perform functional power training 3 times a week together with a personal train

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
2 Years to 15 Years

Inclusion criteria

Inclusion criteria: - Children with cerebral palsy or a related non-progressive disorder between the ages of 4 and 12. - Gross Motor Function Classification System (GMFCS) level I - III. - Parents and/or children have a treatment question related to either walking ability and/or participation of their child.

Exclusion criteria

Exclusion criteria: - Participants that suffer from a progressive neurological disorder. - Treatment with botulinum toxin and/or serial casting in lower extremities planned during the study. - Treatment with botulinum toxin in the 12 weeks prior to the study. - Treatment with serial casting in the 3 weeks prior to the study. - Children that underwent a selective dorsal rhizotomy in the 12 months before participation in the study. - Children that underwent orthopedic surgery on their lower extremities in the 12 months before participation in the study. - Children that have already received MegaPower training in the last 4 months before participation in the study - Children for whom walking is not their preferred method of locomotion (yet).

Design outcomes

Primary

MeasureTime frame
The primary research outcome is an improvement in participation and activity, measured through Goal Attainment Scaling (GAS). Using the GAS, patient-tailored goals will be set up and evaluated using a Likert scale with a reach from -3 (decline) to +2 (much more improvement than original goal). Pre-baseline, the children will undergo the mobility questions of the Canadian Outcome Performance Measure (COPM) together with a therapist. The COPM is especially suited to identify and order personal mobility goals on participation and activity level. After identifying these goals, 1-3 GAS-goals will be written down on both participation and activity level. The child will then have to order their goals and choose a primary goal for both participation and activity. All GAS-goals will be (re-)evaluated at t = 12 weeks (end of intervention), t = 24 weeks (halfway follow-up), and t = 36 weeks (end of follow-up). In case a chosen primary goal cannot be accurately measured or defined using the Likert scale, a secondary goal will become the new primary goal. Only the primary goals will be used for statistical analysis.

Secondary

MeasureTime frame
1. Parent-reported mobility (questionnaires); measured using the Gait Outcomes Assessment List (GOAL) and Mobility Questionnaire (MobQues28). 2. Physical tests for the following paramaters a. Walking speed -> 1-minute walk test b. Aerobic endurance -> 10m shuttle run test c. Anaerobic capacity -> Muscle Power Sprint Test 3. Body composition; measured using bioelectrical impedance analysis (BIA). 4. Dietary intake at baseline (questionnaire); measured using a 3-day food diary in which parents have to track the nutritional intake of their child during 2 week days and 1 weekend day. 5. Physical activity and sleep, measured over a 7-day period using a wrist-wearable accelerometer. 6. Self-perception of the child (questionnaire); measured using Harter's Self-Perception Profile for Children on the domains of social competence, athletic competence, and global self-worth. 7. General baseline characteristics (questionnaire); including: o Age, height, weight, BMI, gender, Gross Motor Function Classification System, CP type, Amsterdam Gait Classification, Selective Control Assessment of Lower Extremities, type of education, education level of their parent(s), use of ankle-foot orthoses. 8. Process evaluation (also see 'aanvullende opmerkingen'). As part of the process evaluation we will also measure parental satisfaction regarding the MegaPower training.

Countries

Netherlands

Contacts

Public ContactR Dersjant

Amsterdam UMC

r.dersjant@amsterdamumc.nl0204440761

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026